CERS Q1 2024 Earnings — Cerus Corporation Revenue & Financial Results | Market Cap Arena

CERSCerus Corporation

$358M

Q1 2024 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$38M+23.9% YoY

Gross Profit

$21M55.4% margin

Operating Income

-$8M-20.8% margin

Net Income

-$10M-25.3% margin

EPS (Diluted)

$-0.05

QoQ Revenue Growth

-18.0%

Cash Flow

Operating Cash Flow

$2M

Free Cash Flow

$860,000

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$189M

Total Liabilities

$139M

Stockholders' Equity

$49M

Cash & Equivalents

$21M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$38M	$31M	+23.9%
Gross Profit	$21M	$17M	+23.1%
Operating Income	-$8M	-$14M	+43.6%
Net Income	-$10M	-$16M	+38.0%

Revenue Segments

Product

$38M88%

Government Contract

$5M12%

Geographic Segments

North America

$25M66%

Europe Middle East And Africa

$13M33%

Other

$178,0000%